Trial · NCT01124149
Adverse events68
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 68
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Colitis ulcerative | Gastrointestinal disorders | MMX Mesalamine/ Mesalazine (Acute Phase) | 10 | 717 | |
| other | Colitis ulcerative | Gastrointestinal disorders | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 43 | 461 | |
| other | Drug ineffective | General disorders | MMX Mesalamine/ Mesalazine (Acute Phase) | 50 | 717 | |
| other | Drug ineffective | General disorders | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 22 | 461 | |
| serious | Myocardial infarction | Cardiac disorders | MMX Mesalamine/ Mesalazine (Acute Phase) | 1 | 717 | |
| serious | Myocardial infarction | Cardiac disorders | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 0 | 461 | |
| serious | Colitis ulcerative | Gastrointestinal disorders | MMX Mesalamine/ Mesalazine (Acute Phase) | 2 | 717 | |
| serious | Colitis ulcerative | Gastrointestinal disorders | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 1 | 461 | |
| serious | Pancreatitis acute | Gastrointestinal disorders | MMX Mesalamine/ Mesalazine (Acute Phase) | 1 | 717 | |
| serious | Pancreatitis acute | Gastrointestinal disorders | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 0 | 461 | |
| serious | Arthritis bacterial | Infections and infestations | MMX Mesalamine/ Mesalazine (Acute Phase) | 1 | 717 | |
| serious | Arthritis bacterial | Infections and infestations | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 0 | 461 | |
| serious | Lung infection | Infections and infestations | MMX Mesalamine/ Mesalazine (Acute Phase) | 1 | 717 | |
| serious | Lung infection | Infections and infestations | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 0 | 461 | |
| serious | Pneumonia staphylococcal | Infections and infestations | MMX Mesalamine/ Mesalazine (Acute Phase) | 1 | 717 | |
| serious | Pneumonia staphylococcal | Infections and infestations | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 0 | 461 | |
| serious | Pyelonephritis acute | Infections and infestations | MMX Mesalamine/ Mesalazine (Acute Phase) | 1 | 717 | |
| serious | Pyelonephritis acute | Infections and infestations | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 0 | 461 | |
| serious | Femoral neck fracture | Injury, poisoning and procedural complications | MMX Mesalamine/ Mesalazine (Acute Phase) | 1 | 717 | |
| serious | Femoral neck fracture | Injury, poisoning and procedural complications | MMX Mesalamine/ Mesalazine (Maintenance Phase) | 0 | 461 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01124149/events